|
EXOC6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.089800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.379760E-01 |
| Normal-vs-Stage2 |
6.180600E-01 |
| Normal-vs-Stage3 |
1.957570E-01 |
| Normal-vs-Stage4 |
2.027800E-01 |
| Stage1-vs-Stage2 |
4.875200E-01 |
| Stage1-vs-Stage3 |
9.275000E-01 |
| Stage1-vs-Stage4 |
7.214600E-01 |
| Stage2-vs-Stage3 |
5.492400E-01 |
| Stage2-vs-Stage4 |
4.459200E-01 |
| Stage3-vs-Stage4 |
6.504200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.432300E-02 |
| Normal-vs-AfricanAmerican |
8.206800E-01 |
| Normal-vs-Asian |
5.908600E-01 |
| Caucasian-vs-AfricanAmerican |
5.426200E-02 |
| Caucasian-vs-Asian |
1.788550E-01 |
| AfricanAmerican-vs-Asian |
5.213000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.183700E-02 |
| Normal-vs-Female |
3.901600E-01 |
| Male-vs-Female |
1.041520E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.783850E-01 |
| Normal-vs-Extreme_Weight |
4.718300E-02 |
| Normal-vs-Obese |
4.476000E-01 |
| Normal-vs-Extreme_Obese |
9.232400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.992000E-01 |
| Normal_Weight-vs-Obese |
4.037000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.190800E-01 |
| Extreme_Weight-vs-Obese |
1.633410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.999200E-01 |
| Obese-vs-Extreme_Obese |
2.100400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.031600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.176000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.098240E-01 |
| Normal-vs-Age(81-100Yrs) |
1.550290E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.208000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.150100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.201000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.452000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.053900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.643050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.648830E-01 |
| Normal-VS-Type2 PRCC |
9.213700E-02 |
| Normal-VS-KIRP CIMP |
3.675200E-01 |
| Normal-VS-Unclassified PRCC |
4.075800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.423800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.773600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.274400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.534100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.104200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.018800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.453500E-02 |
| Normal-vs-N1 |
9.852800E-01 |
| Normal-vs-N2 |
1.296220E-01 |
| N0-vs-N1 |
4.068000E-02 |
| N0-vs-N2 |
5.774200E-01 |
| N1-vs-N2 |
1.324610E-01 |
|
|
